Helical is the virtual AI lab for pharma, designed to turn bio foundation models into reproducible discovery systems so every scientist can test hypotheses in-silico at the speed of inference. The platform has two product surfaces — the Virtual Lab for biologists and translational scientists, and the Model Factory for ML engineers and data scientists - built on the same data, the same models, and the same results. By putting both sides in the same system, Helical closes the gap between computational predictions and biological decision-making, so teams that traditionally worked in silos can collaborate on the same evidence.
Helical
- Life Sciences
- London, United Kingdom
- £7.5m
- helical.bio
- Update Information
More venture news
- 5 Aug 2026

MironidMironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences - 29 Jul 2026

QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences - 7 Jul 2026

Healome TherapeuticsHealome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences
